
The FDA approved adrabetadex for infantile-onset NPC based on a 55% lower risk of death vs external controls, with a boxed warning for hearing loss.
Children who are allergic to eggs can be safely vaccinated for seasonal influenza without risk of serious reaction, says new research.






